Prosthetics. Optune device.
Ended Awarded Last action
- Contract number
- 36C26325N0581
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,583
Award facts
- Contract value 100% obligated
- $16,582.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Omaha, NE 68105, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$82,915 | |
| Original award | $99,497 |
About this award
The Department of Veterans Affairs' Veterans Integrated Service Network 23 awarded a $16,582.91 firm fixed-price delivery order to Novocure Inc. on May 6, 2025, for prosthetics and the Optune device. The delivery order, with a completion date of November 5, 2025, was issued without a set-aside designation and represents a task order under Novocure's existing General Services Administration Medical Equipment and Supplies schedule contract (FSS-65-II-A), valued at $28.85 million and extending through October 31, 2027. Performance will occur in Omaha, Nebraska.
Novocure Inc., a foreign-owned medical device manufacturer specializing in oncology solutions, serves as the prime contractor with no subcontractor involvement. The company provides the Optune system, which utilizes Tumor Treating Fields technology for non-invasive treatment of solid tumor cancers, including FDA-approved applications for glioblastoma and mesothelioma. As the sole source provider of these proprietary devices to the Veterans Health Administration, Novocure has issued over 100 delivery orders across VISNs nationwide since the establishment of the FSS contract in November 2022, enabling the VA to efficiently expand veterans' access to innovative cancer treatment technologies across multiple medical facilities.
Quick answers
Who was awarded contract 36C26325N0581?
36C26325N0581 was awarded to Novocure Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on May 6, 2025.
How much is contract 36C26325N0581 worth?
The government has obligated $16,583 on 36C26325N0581.
Is contract 36C26325N0581 an order under another contract?
Yes. 36C26325N0581 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C26325N0581 competed?
The extent of competition for 36C26325N0581 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award